GL1X · GenesisL1 explorer

MolNFT v1 · #188392 · protein

Delta (B.1.617.2) SARS-cov-2 variant spike protein (S-gsas-delta) in the 2-rbd-up conformation - D3

7TPH · Spike glycoprotein: “Delta (B.1.617.2) SARS-cov-2 variant spike protein (S-gsas-delta) in the 2-rbd-up conformation - D3”. Electron microscopy, 1 ligand (NAG), 20 pockets (best druggability 0.86). MolNFT v1 #188392 on GenesisL1: 3D…

PDB
7TPH
Type
protein
Length
2,912 residues
Chains
3
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike glycoprotein
UniProt
P0DTC2
Ligands
NAG
Pockets
20 · best druggability 0.86

Structure

electron microscopy · 3 distinct chains · 24% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpike glycoproteinprotein96124% helix, 31% strandP0DTC2
BSpike glycoproteinprotein96024% helix, 32% strandP0DTC2
CSpike glycoproteinprotein99124% helix, 32% strandP0DTC2

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 52 copies · chains A, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111780.860.87110empty
28910.850.8794empty
38520.780.8174empty
45480.750.8360empty
54020.740.8547empty

Interfaces

3 interfaces between chains.

  • A–C · 4502 Ų buried · 39 hydrogen bonds · protein-protein
  • A–B · 3974 Ų buried · 30 hydrogen bonds · protein-protein
  • B–C · 3913 Ų buried · 29 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 44 glycan, 35 disulfide (N-glycosylation, disulfide).

Compared structures

  • 7TPH · Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 2-RBD-up… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.